Literature DB >> 2039897

Terodiline with bladder retraining for treating detrusor instability in elderly people.

P A Wiseman1, J Malone-Lee, G S Rai.   

Abstract

OBJECTIVE: To compare terodiline with bladder retraining against placebo with bladder retraining in the treatment of detrusor instability in frail elderly patients.
DESIGN: Randomised, double blind, parallel group study. Treatment lasted for six weeks. Frequency of micturition and episodes of incontinence recorded on diary chart by patients.
SETTING: Incontinence clinic and a geriatric day hospital at two teaching hospitals. PATIENTS: 37 frail but ambulant patients, mean (range) age 80.4 (70-89) years with urinary frequency and urge incontinence, due to detrusor instability. Two patients withdrew before the first assessment (one in each group) and one could not complete the diary chart (placebo group).
INTERVENTIONS: 19 patients received bladder retraining and terodiline 25 mg daily and 18 bladder retraining and placebo. MAIN OUTCOME MEASURES: Change in urinary frequency and number of episodes of incontinence after six weeks' treatment. Patient's subjective evaluation of symptoms.
RESULTS: Little difference was found in the results of treatment with terodiline and placebo. The change in episodes of incontinence per 24 hours was no different in the two groups (95% confidence interval -0.6 to 1.2; p = 0.75) and the difference between treatments in the change in frequency of micturition per 24 hours (-0.2) was not significant (-1.1 to 1.2; p = 0.76). Ten patients taking terodiline thought they had improved compared with seven receiving placebo; this difference was not significant.
CONCLUSION: Although the number of patients in each group was small and may have been insufficient to detect a drug effect, the possible benefit of terodiline is likely to be small.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039897      PMCID: PMC1669297          DOI: 10.1136/bmj.302.6783.994

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  4 in total

1.  Single- and multiple-dose pharmacokinetics of terodiline in geriatric patients.

Authors:  B Hallén; A Magnusson; S Bogentoft; P Ekelund
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  A reassessment of bladder training in detrusor dysfunction in the female.

Authors:  W K Frewen
Journal:  Br J Urol       Date:  1982-08

3.  Evaluation of long-term safety and clinical benefit of terodiline in women with urgency/urge incontinence. A multicentre study.

Authors:  W Fischer-Rasmussen
Journal:  Scand J Urol Nephrol Suppl       Date:  1984

4.  Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.

Authors:  D Peters
Journal:  Scand J Urol Nephrol Suppl       Date:  1984
  4 in total
  7 in total

1.  Terodiline for treating detrusor instability in elderly people.

Authors:  S W Davies; S J Brecker; R N Stevenson
Journal:  BMJ       Date:  1991-05-25

2.  Terodiline for treating detrusor instability in elderly people.

Authors:  G Boyd
Journal:  BMJ       Date:  1991-07-13

Review 3.  Economics of lower urinary tract symptoms (LUTS) in older people.

Authors:  U Azam; M Castleden; D Turner
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

Review 4.  Anticholinergic drugs versus non-drug active therapies for non-neurogenic overactive bladder syndrome in adults.

Authors:  Bhavan Prasad Rai; June D Cody; Ammar Alhasso; Laurence Stewart
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

Review 5.  Timed voiding for the management of urinary incontinence in adults.

Authors:  J Ostaszkiewicz; L Johnston; B Roe
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 6.  Bladder training for urinary incontinence in adults.

Authors:  S A Wallace; B Roe; K Williams; M Palmer
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 7.  Habit retraining for the management of urinary incontinence in adults.

Authors:  J Ostaszkiewicz; L Johnston; B Roe
Journal:  Cochrane Database Syst Rev       Date:  2004
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.